Dna X (SONM) Other Operating Expenses (2018 - 2025)

Dna X has reported Other Operating Expenses for 8 years, with the latest figure at -$11.9 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses rose 54.75% year-over-year to -$11.9 million; the trailing twelve-month figure through Mar 2026 stood at -$6.0 million (up 67.53% YoY), and the FY2024 full-year result was -$14.7 million, down 268.21% from the prior year.
• Other Operating Expenses for Q4 2025 stood at -$11.9 million, down from $2.5 million in the prior quarter.
• The five-year high for Other Operating Expenses was $6.4 million in Q2 2024, with the low at -$26.2 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $493300.0 across 5 years, with a median of $2.3 million in 2022.
• The largest YoY upside for Other Operating Expenses was 252.27% in 2024 against a maximum downside of 959.0% in 2024.
• Dna X's Other Operating Expenses stood at $4.7 million in 2021, then plunged by 67.68% to $1.5 million in 2022, then jumped by 100.72% to $3.1 million in 2023, then slumped by 959.0% to -$26.2 million in 2024, then surged by 54.75% to -$11.9 million in 2025.
• The last three Other Operating Expenses figures came in at -$11.9 million (Q4 2025), $2.5 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.